| Dear Investor, On September 10, 2018, a tiny Cambridge biotech firm won a patent on a new kind of genetic software that can "Cut & Paste" any disease from your body. This revolutionary new kind of treatment will not just change medicine - It has the prospective to banish genetic disease from our species. If that sounds like science fiction, consider this -
And the biggest drug companies have rushed to invest over a $1B in the past year alone - Juno Pharma invested $700M. Glaxo SmithKline invested $350M. Johnson and Johnson invested $292M. That's on top of the $120M Bill Gates and Google Ventures already invested into this. The list goes on and on... Never before has so much money invested in a new treatment so quickly. Investor's Business Daily estimates the market is worth at least $75B market. That's if the company doesn't get taken over for quick 300% gains first. Sincerely,  "The Buck Stops Here" Dylan Jovine This is a PAID ADVERTISEMENT provided to the customers of StockEarnings. Although we have sent you this email, StockEarnings does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe. StockEarnings |
No comments:
Post a Comment